These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8391748)

  • 1. Clinical evaluation of the use-dependent QRS prolongation and the reverse use-dependent QT prolongation of class I and class III antiarrhythmic agents and their value in predicting efficacy.
    Sadanaga T; Ogawa S; Okada Y; Tsutsumi N; Iwanaga S; Yoshikawa T; Akaishi M; Handa S
    Am Heart J; 1993 Jul; 126(1):114-21. PubMed ID: 8391748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical significance of the use-dependent sodium channel block and reverse use-dependent potassium channel block of class I and class III antiarrhythmic agents and their values to predict drug efficacy].
    Sadanaga T; Ogawa S; Okada Y; Handa S
    Jpn Circ J; 1992; 56 Suppl 5():1474-6. PubMed ID: 1337923
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessment of reverse use-dependent blocking actions of class III antiarrhythmic drugs by 24-hour Holter electrocardiography.
    Okada Y; Ogawa S; Sadanaga T; Mitamura H
    J Am Coll Cardiol; 1996 Jan; 27(1):84-9. PubMed ID: 8522715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Estimation of depressant effects of class I antiarrhythmic drugs on intraventricular conduction--rate-dependent effects on QRS duration].
    Ikeda N; Kamiya K
    Jpn Circ J; 1992; 56 Suppl 5():1477-9. PubMed ID: 1337924
    [No Abstract]   [Full Text] [Related]  

  • 5. Ischemia enhances use-dependent sodium channel blockade by pilsicainide, a class IC antiarrhythmic agent.
    Sadanaga T; Ogawa S
    J Am Coll Cardiol; 1994 May; 23(6):1378-81. PubMed ID: 8176096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of 2,4-dinitrophenol induced ATP sensitive potassium current in guinea pig ventricular myocytes by class I antiarrhythmic drugs.
    Wu B; Sato T; Kiyosue T; Arita M
    Cardiovasc Res; 1992 Nov; 26(11):1095-101. PubMed ID: 1291087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome.
    Shimizu W; Antzelevitch C; Suyama K; Kurita T; Taguchi A; Aihara N; Takaki H; Sunagawa K; Kamakura S
    J Cardiovasc Electrophysiol; 2000 Dec; 11(12):1320-9. PubMed ID: 11196553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antiarrhythmic effects of pilsicainide hydrochloride and effects on cardiac function and ECG in dogs: comparison with disopyramide].
    Hidaka T; Inoue T; Komoriya K; Hayashi Y; Inomata N
    Nihon Yakurigaku Zasshi; 2000 May; 115(5):295-308. PubMed ID: 10872181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessments of the QT/QRS restitution in perfused guinea-pig heart can discriminate safe and arrhythmogenic drugs.
    Osadchii OE
    J Pharmacol Toxicol Methods; 2017 Sep; 87():27-37. PubMed ID: 28552278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind, crossover comparison of flecainide acetate and disopyramide phosphate in the treatment of ventricular premature complexes.
    Kjekshus J; Bathen J; Orning OM; Storstein L
    Am J Cardiol; 1984 Feb; 53(5):72B-78B. PubMed ID: 6421140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency dependent effects of class I antiarrhythmic agents studied in patients with implanted pacemakers.
    Takanaka C; Lee JK; Nonokawa M; Sugiyama T; Yame S
    Pacing Clin Electrophysiol; 1994 Nov; 17(11 Pt 2):2100-5. PubMed ID: 7845825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of frequency-dependent conduction delay by class I antiarrhythmic drugs in human atrium.
    Sakai R; Inoue D; Ishibashi K; Inoue M; Shirayama T; Yamahara Y; Asayama J; Nakagawa M
    J Cardiovasc Pharmacol; 1995 Jun; 25(6):953-60. PubMed ID: 7564341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico assessment of the effects of quinidine, disopyramide and E-4031 on short QT syndrome variant 1 in the human ventricles.
    Luo C; Wang K; Zhang H
    PLoS One; 2017; 12(6):e0179515. PubMed ID: 28632743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Class 1 antiarrhythmic drugs--characteristic electrocardiographic differences when assessed by atrial and ventricular pacing.
    Milne JR; Hellestrand KJ; Bexton RS; Burnett PJ; Debbas NM; Camm AJ
    Eur Heart J; 1984 Feb; 5(2):99-107. PubMed ID: 6723689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QT-prolonging class I drug, disopyramide, does not aggravate but suppresses adrenaline-induced arrhythmias. Comparison with cibenzoline and pilsicainide.
    Miyamoto S; Zhu B; Teramatsu T; Aye NN; Hashimoto K
    Eur J Pharmacol; 2000 Jul; 400(2-3):263-9. PubMed ID: 10988343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrocardiographic interactions between pinacidil, a potassium channel opener and class I antiarrhythmic agents in guinea-pig isolated perfused heart.
    Yang Q; Padrini R; Bova S; Piovan D; Magnolfi G
    Br J Pharmacol; 1995 Apr; 114(8):1745-9. PubMed ID: 7599944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of E4031, a class III antiarrhythmic drug, on ischemia- and reperfusion-induced arrhythmias in isolated rat hearts.
    Shinmura K; Tani M; Hasegawa H; Ebihara Y; Nakamura Y
    Jpn Heart J; 1998 Mar; 39(2):183-97. PubMed ID: 9687827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complex frequency-dependent interaction of class-I antiarrhythmic drugs as they affect intraventricular conduction.
    Lee JK; Takanaka C; Nonokawa M; Kato H; Yabe S; Kodama I; Toyama J
    Eur Heart J; 1995 Jun; 16(6):832-41. PubMed ID: 7588928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of encainide and disopyramide in chronic ventricular arrhythmias: a double-blind placebo-controlled crossover study.
    Caron JF; Libersa CC; Kher AR; Kacet S; Wanszelbaum H; Dupuis BA; Poirier JM; Lekieffre JP
    J Am Coll Cardiol; 1985 Jun; 5(6):1457-63. PubMed ID: 2582017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of disopyramide and mexiletine on the terminal repolarization process of the in situ heart assessed using the halothane-anesthetized in vivo canine model.
    Yoshida H; Sugiyama A; Satoh Y; Ishida Y; Kugiyama K; Hashimoto K
    Circ J; 2002 Sep; 66(9):857-62. PubMed ID: 12224826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.